Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Regulatoriskt pressmeddelande

RLS Global AB: RLS Global initiates strategic review process aiming to commercialize ChloraSolv

RLS Global
Läs börsmeddelandet

The RLS Global Board of Directors has resolved to initiate a strategic review process to enable the commercial roll out of ChloraSolv across European markets.

RLS Global announced earlier today that RLS Global and Convatec have agreed to terminate the collaboration agreement. RLS Global and Convatec have agreed that both parties will work jointly and with the common target to have a smooth handover from Convatec to RLS Global.

The RLS Global Board of Directors will consider all strategic options, including a partnership, a sale of the company, a sale of ChloraSolv, or a financial investment in RLS Global.

"The review process will be undertaken with immediate effect, and we have set no timeline for completion of this process", says Lars Johansson, Chairman of the Board, RLS Global.

"Bringing ChloraSolv to patients will require resources and capital that RLS Global does not have as of today, and hence we are now initiating a strategic review process," Lars Johansson continues.

RLS Global (publ) is obliged to make the information contained herein public pursuant to the EU market abuse regulation (MAR). The information was submitted for publication through the agency of the contact person, 09-11-2023 22:15 CET.

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.